A World Free from Huntington Disease

Western University and Huntington Society of Canada announce the creation of a prestigious endowed research chair – a first-of-its-kind in North America

Imagine a disease that has the symptoms of Alzheimer’s disease, Parkinson’s disease, and ALS all at once.

Huntington disease (HD) is a hereditary, neurodegenerative, illness with physical, cognitive, and emotional symptoms. To date, there are no drug treatments that stop its progression.

With the goal to advance patient care outcomes and accelerate life-changing treatments, Western University and Huntington Society of Canada have partnered together to create an endowed research chair that will pave the way for accelerated advances in HD research.

“The goal is to bring learnings from the laboratory to the bedside to the community to make a significant difference in the lives of people facing Huntington disease and other neurodegenerative disorders.”

“Huntington Society of Canada Research Chair is a first-of-its-kind in North America,” says Dr. John Yoo, Dean of Schulich School of Medicine & Dentistry. “The goal is to bring learnings from the laboratory to the bedside to the community to make a significant difference in the lives of people facing Huntington disease and other neurodegenerative disorders.”

This research chair joins other research initiatives that are helping to get closer to a world free from HD.

Watch a message from Dean Yoo about the Huntington Society of Canada Chair announcement.